Pharmacy |
| ||
|
Somac Protonix |
|
| ||
Home » Prescription Drugs 15 » Somac Protonix IndicationsI. For the symptomatic improvement and healing of gastrointestinal diseases which require a reduction in acid secretion: 1.Duodenal ulcer 2.Gastric ulcer 3.Gastro-oesophageal reflux disease (GORD) - For the treatment of mild reflux disease and associated symptoms (e.g. heartburn acid regurgitation pain on swallowing) - Reflux oesophagitis 4.Zollinger-Ellison Syndrome II. Eradication of Helicobacter pylori (hereinafter referred to as H. pylori) in combination with -clarithromycin and amoxycillin or -clarithromycin and metronidazole or -amoxycillin and metronidazoleIII. Prevention of gastroduodenal ulcers induced by non-selective non-steroidal anti-inflammatory drugs (NSAIDs) in patients at risk with a need for continuous NSAID treatment. Dosage and AdministrationDuodenal UlcerThe recommended oral dosage is one gastro-resistant tablet SOMAC 40mg per day. A duodenal ulcer generally heals within 2 weeks. If a 2-week period of treatment is not sufficient healing will be achieved in almost all cases within a further 2 weeks.Gastric UlcerThe recommended oral dosage is one gastro-resistant tablet SOMAC 40mg per day.A 4-week period is usually required for the treatment of gastric ulcers. If this is not sufficient healing will usually be achieved within a further 4 weeks.GORDFor mild reflux disease and the associated symptoms the recommended dosage is one SOMAC 20mg tablet per day. Symptom relief is generally accomplished within 2-4 weeks. If symptom control has not been achieved after four weeks treatment with SOMAC 20mg tablets daily further investigation is recommended.For treatment of reflux oesophagitis the recommended oral dosage is one SOMAC 40mg tablet per day. A 4-week period is usually required for treatment of reflux oesophagitis however if this is not sufficient healing will usually be achieved within a further 4 weeks.Zollinger-Ellison SyndromeThe recommended oral dosage is one gastro-resistant tablet SOMAC 40mg per day.Prevention of gastroduodenal ulcers induced by non-selective non-steroidal anti-inflammatory drugs (NSAIDs) in patients at risk with a need for continuous NSAID treatment.The recommended oral dosage is one gastro-resistant tablet SOMAC 20mg per day.MaintenanceDuodenal and Gastric Ulcer and Zollinger-Ellison Syndrome:For long-term management a maintenance dose of one gastro-resistant tablet SOMAC 40mg per day is recommended.Reflux OesophagitisA maintenance dose of one SOMAC 20mg tablet per day is recommended increasing to 40mg per day if relapse occurs. After healing of the relapse the dosage can be reduced again to 20mg SOMAC.Experience with long-term administration in man over several years is available in a limited number of patients. Therefore long-term treatment exceeding 1 year may be considered after careful evaluation of the risk benefit ratio. Patients should then be kept under regular surveillance.Use in childrenThere are no data currently available on the use of pantoprazole in children.Use in the elderlyThe daily dose of 20 mg or 40mg can be given. An exception is combination therapy for eradication of H. pylori where also elderly patients should receive the usual pantoprazole dose (2 x 40mg/day) during 1-week treatment.Impaired Renal FunctionThe daily dose of 20mg or 40mg can be given.Impaired Liver FunctionIn patients with severe liver impairment the dose has to be reduced to 20mg pantoprazole per day. Buy Somac Protonix and other Prescription Drugs 15 products online at Medstore. Buy Online at Medstore - Click Here!
About Somac Protonix: Product Type: Prescription Drugs 15 Somac ( Protonix Generic Pantoprazole ) Somac (Protonix Generic Pantoprazole) Protonix Generic Pantoprazole 20mg Protonix Generic Pantoprazole Somac
View more Prescription Drugs 15 Pharmacy: Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide: Which drugs are scheduled to go generic? Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.
| ||
